BEGIN:VCALENDAR
VERSION:1.0
PRODID:BIOCOM Events
BEGIN:VEVENT
DTSTART:20090819T073000-0700
DTEND:20090819T120000-0700
LOCATION:Mintz Levin-San Diego
DESCRIPTION;ENCODING=QUOTED-PRINTABLE:Meet and Greet with the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Development Center Directors This program offers an exclusive opportunity for BIOCOM members to learn more about the latest Small Business Research Funding Opportunities. Attendees will hear directly from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) Development Center Directors, who will give an in depth overview of the latest NCI SBIR & STTR Programs and opportunities available. In addition, NCI will provide valuable tips on applying for funding through the program.Click HERE to View AgendaSpeakers=0D=0A=Michael Weingarten, Director, NCI SBIR Development Center, National Cancer Institute=0D=0A=Michael Weingarten is the Director for the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute, one of 27 Institutes of the National Institutes of Health (NIH) in Bethesda, Md.  In this role, Mr. Weingarten manages all aspects of the NCI SBIR and Small Business Technology Transfer (STTR) programs including a portfolio of over $100M in grants and contracts annually.  The SBIR and STTR programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.  In his current role, Mr. Weingarten led a team that developed a set of key recommendations for optimizing the performance of the NCI SBIR program at the NIH.  Those recommendations included the establishment of an SBIR Development Center to manage the NCI SBIR program.  This Center is staffed with talented leaders from both industry and the NIH who have expertise in the development and commercialization of technology in the cancer field to optimize the returns the NCI achieves through this program.   =0D=0A=Ali Andalibi, Ph.D., Program Director, NCI SBIR Development Center, National Cancer Institute=0D=0A=Dr. Ali Andalibi is a molecular biologist and geneticist by training with extensive experience in both academia and industry. He received his PhD from the UCLA department of Microbiology and Molecular Genetics and later joined the faculty in the UCLA department of Medicine. After leaving UCLA he was involved in several early stage biotechnology companies. He then joined the House Ear Institute (HEI), where he served as the Director of New Technology and Project Development and was also an adjunct Assistant Professor of Otolaryngology, at the University of Southern California, School of Medicine. Dr. Andalibi then joined the National Science Foundation as a Program Director in the Division of Industrial Innovation and Partnerships, where he oversaw the NSF's medical biotechnology SBIR/STTR grant portfolio. Dr. Andalibi is currently a Program Director in the National Cancer Institute's SBIR Development Center, where he leads the Therapeutics Cluster.=0D=0A=New funding opportunities that will be coverered include the following:=0D=0A= =0D=0A=SBIR Phase II Bridge Award=0D=0A=The new Phase II Bridge award is specifically designed to augment previously funded NIH-wide SBIR Phase II projects that require additional funding in order to achieve key technical and regulatory milestones along the path toward commercialization. Phase II Bridge Award applicants may request budgets up to $1 million in total costs per year and project periods up to three years (a total of $3 million over three years) from the NCI.Following this workshop, BIOCOM member's will have an opportunity to schedule private meetings with Mr. Michael Weingarten, the Director of the NCI SBIR Development Center, or Dr. Ali Andalibi, the Program Director of the NCI SBIR Development Center.Directions to Mintz Levin Offices:=0D=0A=From the South (e.g. Lindbergh Field)=0D=0A= • Take I-5 North to the Local (I-805) Bypass (on the right just past Genesee Road)=0D=0A= • Exit at Carmel Mountain Road=0D=0A= • At the end of the off ramp turn right (East) onto Carmel Mountain Road=0D=0A= • Immediately at the first signal light (one-half block) turn left on Gateway Ridge Court=0D=0A= • Mintz Levin is in the second building (# 3580). Make sure to turn right at the second driveway and pull into the parking structure.   =0D=0A==0D=0A=From the North (e.g. Orange County)=0D=0A= • Take I-5 South to the Local (I-805) Bypass (on the right just past Carmel Valley Road)=0D=0A= • Exit at Carmel Mountain Road=0D=0A= • At the end of the off ramp turn left (East) onto Carmel Mountain Road=0D=0A= • Proceed under the freeway and, at the second signal light, turn left on Gateway Ridge Court=0D=0A= • Mintz Levin is in the second building (# 3580). Make sure to turn right at the second driveway and pull into the parking structure.From the East (e.g. Riverside)=0D=0A=• Take I-15 South to Hwy 56 (Ted Williams Parkway)• Proceed West on Hwy 56, which will turn south just past El Camino Real and merge onto the Local (I-5/I-805)  Bypass=0D=0A= • Exit at Carmel Mountain Road (on the right just after Hwy 56 merges into the Bypass to I-5/I-805)=0D=0A= • At the end of the off ramp turn left (East) onto Carmel Mountain Road=0D=0A= • Proceed under the freeway and, at the second signal light, turn left on Gateway Ridge Court=0D=0A= • Mintz Levin is in the second building (# 3580). Make sure to turn right at the second driveway and pull into the parking structure.   =0D=0A==0D=0A=Parking: =0D=0A=Parking is available in the building parking garage free of charge.

SUMMARY:Meet and Greet with the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Development Center Directors  
END:VEVENT
END:VCALENDAR